IINN inspira-technologies.com: Debt to Book Capitalization Ratio

Official company branding of Inspira Technologies Oxy B.H.N. Ltd (IINN)

Inspira Technologies Oxy is mitigating risks through the global implementation of non-invasive respiratory support systems. The company's ratio of financial debt to equity clearly illustrates its financial stability, with the indicator standing at 0.62. The market launch of ART technology and FDA approval will drive growth, while current quotes already price in development costs and regulatory complexities.

Inspira Technologies Oxy B.H.N. Ltd. - IINN Debts to Book Capitalization (period 07/04/2022 - 05/20/2026)
Product sample of Inspira Technologies Oxy B.H.N. Ltd.

A comparative asset analysis allows for an assessment of capital structure stability through the debt-to-equity ratio. This metric measures the proportion of borrowed funds relative to the company's book value, where the value 0.62 reflects the current level of financial leverage. For Inspira Technologies (IINN), this is critical due to unstable cash flows during the equipment commercialization stage. An increase in this indicator signals risks in the event of certification delays. By analyzing the current ratio of debt to book capital, an investor determines the business's margin of safety.

Competing companies

Debts to Book Capitalization DXCM (DexCom, Inc.)|penumbrainc.com (PEN) - Debts to Book Value|NOVT - Debt to Book Capitalization Ratio|Debt to Net Assets Ratio HAE (Haemonetics Corp)|INSP: Debts to Book Capitalization|Procept (PRCT) - Debts to Book Capitalization|Debt to Book Capitalization Ratio CONMED Corporation|pulsebiosciences.com - Debts to Book Capitalization Ratio|Debts to Book Capitalization INMD|PMI - Debts to Book Value|Surmodics Corp - Debt to Book Value|Debts to Book Capitalization Senseonics SENS|NPCE: Debt to Book Value|Tactile Systems Technology - Debt to Book Capital|SNWV: Debts to Book Capitalization|OM - Debts to Net Assets|ELMD (SmartVest) - Debts to Book Capitalization|Debt to Book Value LENSAR Inc (LNSR)|Debt to Book Value RCEL (AVITA Medical, Inc.)|PROF (profoundmedical.com) - Debt to Net Assets Ratio|Debt to Book Capitalization Ratio Baird Medical BDMD|EDAP - Debt to Book Value|Bovie Medical - Debts to Book Capitalization|Debts to Book Value IceCure Medical Ltd|LUNG: Debts to Book Capitalization|Debt to Book Value Ratio TELA|CTSO (CytoSorbents Corp) - Debts to Book Capitalization|Sensus Healthcare Inc (SRTS) - Debts to Net Assets|Debts to Book Capitalization ZYXI|Debt to Book Value electrocore.com ECOR|Debts to Book Capitalization RBOT (Vicarious Surgical)|Debts to Book Capitalization seastarmedical.com ICU|IRIX - Debt to Book Capitalization Ratio|INBS: Debt to Book Capitalization Ratio|XAIR (beyondair.net) - Debt to Book Value|Profusa, Inc - Debt to Net Assets Ratio|SSKN (STRATA Skin Sciences Inc.) - Debts to Book Capitalization|Debts to Book Value glucotrack.com GCTK|Debt to Book Capitalization Ratio NanoVibronix (NAOV)|Venus Concept Inc (VERO) - Debt to Net Assets|CHF Solutions - Debt to Book Value|Debts to Book Capitalization Aethlon Medical Corp AEMD|TransEnterix - Debts to Book Capitalization|Debts to Net Assets avinger.com AVGR|Biosig Technologies (BSGM) - Debt to Book Capitalization Ratio|Debts to Book Capitalization Ratio CUTR (Cutera Inc.)|Debt to Book Capitalization Ratio Know Labs Corp|Debt to Book Value Inari Medical Corp (NARI)|Debts to Book Capitalization NVRO|RSLS - Debts to Book Value|Debt to Book Capitalization Ratio Silk Road Medical SILK